Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam D Devore

Showing results (321-330 of 339) with videos related to

Pageof 34
Sort By:
JACC. Basic to Translational Science|March 26, 2025
Metabolic and Pharmacokinetic Profiling of a Ketone Ester by Background SGLT2 Inhibitor Therapy in HFrEFSenthil Selvaraj, Lydia Coulter Kwee, Elizabeth J Thompson, et al.
JACC. Heart Failure|June 15, 2020
Splanchnic Nerve Block for Chronic Heart FailureMarat Fudim, Richard L Boortz-Marx, Arun Ganesh, et al.
Journal of Cardiac Failure|September 27, 2023
Medical Therapy Before, During and After Hospitalization in Medicare Beneficiaries With Heart Failure and Diabetes: Get With The Guidelines - Heart Failure RegistryAnkeet S Bhatt, Gregg C Fonarow, Stephen J Greene, et al.
JACC. Heart Failure|May 10, 2024
Cause-Specific Health Care Costs Following Hospitalization for Heart Failure and Cost Offset With SGLT2i TherapyVeraprapas Kittipibul, Muthiah Vaduganathan, Uchechukwu Ikeaba, et al.
Journal of the American Heart Association|September 8, 2022
Heart Failure Strategically Focused Research Network: Summary of Results and Future DirectionsG Michael Felker, Peter Buttrick, Anthony Rosenzweig, et al.
JACC. Cardiovascular Interventions|October 20, 2022
Position Statement on Vascular Access Safety for Percutaneous Devices in AMI Complicated by Cardiogenic ShockAbdulla A Damluji, Behnam Tehrani, Shashank S Sinha, et al.
Journal of Cardiac Failure|April 24, 2022
Health System-Level Performance in Prescribing Guideline-Directed Medical Therapy for Patients With Heart Failure With Reduced Ejection Fraction: Results From the CONNECT-HF TrialBradi B Granger, Lisa A Kaltenbach, Gregg C Fonarow, et al.
JACC. Heart Failure|July 10, 2020
Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction: Rationale and Design of the LIFE TrialDouglas L Mann, Stephen J Greene, Michael M Givertz, et al.
JAMA Cardiology|May 29, 2024
Kidney Outcomes Among Medicare Beneficiaries After Hospitalization for Heart FailureJohn W Ostrominski, Stephen J Greene, Ravi B Patel, et al.
American Heart Journal|September 27, 2020
PROVIDE-HF primary results: Patient-Reported Outcomes inVestigation following Initiation of Drug therapy with Entresto (sacubitril/valsartan) in heart failureRobert J Mentz, Haolin Xu, Emily C O'Brien, et al.
Pageof 34

Showing results (321-330 of 339) with videos related to

Sort By:
Pageof 34
JACC. Basic to Translational Science|March 26, 2025
Metabolic and Pharmacokinetic Profiling of a Ketone Ester by Background SGLT2 Inhibitor Therapy in HFrEFSenthil Selvaraj, Lydia Coulter Kwee, Elizabeth J Thompson, et al.
JACC. Heart Failure|June 15, 2020
Splanchnic Nerve Block for Chronic Heart FailureMarat Fudim, Richard L Boortz-Marx, Arun Ganesh, et al.
Journal of Cardiac Failure|September 27, 2023
Medical Therapy Before, During and After Hospitalization in Medicare Beneficiaries With Heart Failure and Diabetes: Get With The Guidelines - Heart Failure RegistryAnkeet S Bhatt, Gregg C Fonarow, Stephen J Greene, et al.
JACC. Heart Failure|May 10, 2024
Cause-Specific Health Care Costs Following Hospitalization for Heart Failure and Cost Offset With SGLT2i TherapyVeraprapas Kittipibul, Muthiah Vaduganathan, Uchechukwu Ikeaba, et al.
Journal of the American Heart Association|September 8, 2022
Heart Failure Strategically Focused Research Network: Summary of Results and Future DirectionsG Michael Felker, Peter Buttrick, Anthony Rosenzweig, et al.
JACC. Cardiovascular Interventions|October 20, 2022
Position Statement on Vascular Access Safety for Percutaneous Devices in AMI Complicated by Cardiogenic ShockAbdulla A Damluji, Behnam Tehrani, Shashank S Sinha, et al.
Journal of Cardiac Failure|April 24, 2022
Health System-Level Performance in Prescribing Guideline-Directed Medical Therapy for Patients With Heart Failure With Reduced Ejection Fraction: Results From the CONNECT-HF TrialBradi B Granger, Lisa A Kaltenbach, Gregg C Fonarow, et al.
JACC. Heart Failure|July 10, 2020
Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction: Rationale and Design of the LIFE TrialDouglas L Mann, Stephen J Greene, Michael M Givertz, et al.
JAMA Cardiology|May 29, 2024
Kidney Outcomes Among Medicare Beneficiaries After Hospitalization for Heart FailureJohn W Ostrominski, Stephen J Greene, Ravi B Patel, et al.
American Heart Journal|September 27, 2020
PROVIDE-HF primary results: Patient-Reported Outcomes inVestigation following Initiation of Drug therapy with Entresto (sacubitril/valsartan) in heart failureRobert J Mentz, Haolin Xu, Emily C O'Brien, et al.
Pageof 34